Synthetic Oligonucleotides Market

SEE the Table of Contents.

GET the Free Sample of this Report.

Many organizations subscribe to some or all of our reports.  You may already have free access to this report. FIND out Here.

“Oligonucleotide Synthesis Markets 3^rd Edition. Forecasts by Oligo Length, Application, Category, Type, Product, and Region. With Executive and Consultant Guides. 2025 to 2029.  Includes Impact of Aritificial Intelligence."

406 Pages packed with information 

Our facts and support = Your success.

Synthetic Oligonucleotides are poised for explosive growth as gene technology moves into mainstream healthcare, food production and, even, data storage.  With Synthetic DNA, organisms, like algae, are “custom designed” to produce food and medicine while consuming few resources.  “Oligos” are already hard at work in both mature and emerging market segments.  The possibilities, and market growth are unlimited.  Our analysis shows that investors do not yet understand the scope of this technology and the enormous market opportunity.  Small biotechs could become huge multinationals, all based on producing DNA and its building blocks.  Learn all about it and see our forecasts in this comprehensive report.

 This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity.  The technology is moving fast.  It is coming out of the lab and onto the desktop as genomics itself crosses the chasm.

All report data is available in Excel format on request.

SEE the Table of Contents.

GET the Free Sample of this Report.

Many organizations subscribe to some or all of our reports.  You may already have free access to this report. FIND out Here.

ABOUT THE LEAD AUTHOR

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research.  His education includes:

Finance for Senior Executives - Harvard Business School

Market Research  - Burke Institute

M.B.A. (Finance and Policy) - University of British Columbia

B.Sc. (Chemistry) - University of British Columbia

He is an experienced business and clinical professional.  He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping."  He has worked in laboratory testing and management for over 20 years.